BBR Partners’s Labcorp LH Stock Holding History

BBR Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,044	Closed	-$545K	–	262
2026 Q1	$545K	Buy	+2,044	New	+$553K	0.03%	145
2024 Q1	–	Sell	-883	Closed	-$201K	–	260
2023 Q4	$201K	Buy	+883	New	+$185K	0.02%	175

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBR Partners's LH Position: Q2 2026 in Review

BBR Partners sold out of Labcorp (LH) in Q2 2026, closing a stake of 2,044 shares — an estimated $545K sold.

BBR Partners first reported a position in LH in Q4 2023 and held it in 2 quarters. The position peaked at $545K in Q1 2026. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

BBR Partners reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
BBR Partners sold 2,044 Labcorp shares in Q2 2026, an estimated $545K.
BBR Partners first reported a position in Labcorp in Q4 2023 and held it in 2 quarters.
BBR Partners's Labcorp position peaked at $545K in Q1 2026.
1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on BBR Partners's 13F filing for Q2 2026, filed 11 Aug 2026.